Common Contracts
2 similar Exclusive License Agreement contracts by Terns Pharmaceuticals, Inc.
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • January 15th, 2021 • Terns Pharmaceuticals, Inc. • Pharmaceutical preparations
This Exclusive License Agreement (this “Agreement”), effective as of March 9, 2018 (the “Effective Date”), is entered into by and among Terns Pharmaceuticals, Inc., an exempted company incorporated under the laws of the Cayman Islands having a place of business P. O. Box 613, Harbor Center, George Town, Grand Cayman KYl-1107, Cayman Islands (“Terns”) and Eli Lilly and Company, a U.S.A. company, organized and existing under the laws of the State of Indiana, having a place of business at Lilly Corporate Center, Indianapolis, Indiana 46285, USA (“Lilly”). Lilly and Terns may be referred to herein individually as a “Party” or collectively as the “Parties.” Reference to a Party shall be deemed to include that Party’s Affiliates.
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • January 15th, 2021 • Terns Pharmaceuticals, Inc. • Pharmaceutical preparations
This Exclusive License Agreement (this “Agreement”), effective as of February 9, 2018 (the “Effective Date”), is entered into by and among Terns Pharmaceuticals, Inc., an exempted company incorporated under the laws of the Cayman Islands having a place of business P.O. Box 613, Harbor Center, George Town, Grand Cayman KY1-1107, Cayman Islands (“Terns”) and Eli Lilly and Company, a U.S.A. company, organized and existing under the laws of the State of Indiana, having a place of business at Lilly Corporate Center, Indianapolis, Indiana 46285, USA (“Lilly”). Lilly and Terns may be referred to herein individually as a “Party” or collectively as the “Parties.” Reference to a Party shall be deemed to include that Party’s Affiliates.
